Combination of medication for treating gallbladder disease and preparation method

A composition and drug technology, applied in the field of pharmaceutical composition for the treatment of gallbladder disease and its preparation, can solve the problems of affecting the curative effect, easily damaging the spleen and stomach, simply clearing away heat and removing dampness, etc., and achieve good curative effect

Active Publication Date: 2005-08-31
NANJING TONGRENTANG PHARM CO LTD
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In short, for patients with cholelithiasis, due to liver and gallbladder damp-heat stagnation for a long time, long-term use of heat-clearing and damp-dispelling drugs will consume righteousness, and easily damage the spleen and stomach, resu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 1. Phase II clinical research

[0032] Phase II Clinical Study of the Pharmaceutical Composition of the Present Invention in the Treatment of Cholelithiasis Complicated by Chronic Cholecystitis with Damp-Heat and Qi and Blood Stasis Syndrome

[0033] Approval number: State Drug Administration No. 2001ZL250

[0034] Test center: Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, West China Hospital of Sichuan University (First Affiliated Hospital of West China University of Medical Sciences), Affiliated Hospital of Shaanxi Academy of Traditional Chinese Medicine

[0035] Purpose of the test: To evaluate the efficacy and safety of the pharmaceutical composition granules of the present invention in treating cholelithiasis complicated with chronic cholecystitis with damp-heat and qi-blood stasis syndrome

[0036] Experimental design: stratified block randomized, parallel cont...

Embodiment 2

[0072] The raw medicinal materials used in the pharmaceutical composition of the present invention are all pharmacopoeia varieties, and all are commercially available decoction pieces.

[0073] Prescription: Desmodium 5 grams, Gardenia 2.5 grams, Phellodendron 1.7 grams, Cassia 2 grams, Rhizoma Chuanxiong 1.7 grams, Magnolia officinalis 2 grams, Cortex Moutan 1.7 grams, Sun-dried ginseng 1 gram, Guizhi 1.7 grams, Capillaris 2.5 grams, 1 gram of rhubarb, 1.7 grams of French pinellia, 2.5 grams of hawthorn, 1.7 grams of peach kernel, 1 gram of safflower, 2.5 grams of Cyperus cypress, 1.7 grams of citrus aurantium, and 1.7 grams of woody fragrance.

[0074] 1. Take the prescribed amount of magnolia officinalis, rhubarb, cassia seed, raw sun-dried ginseng, and Pinellia five flavors and grind them into coarse powder, use 60% ethanol as solvent, soak for 24 hours, percolate, collect 6 times the amount at a collection speed of 3ml / min (Based on the weight of medicinal materials), rec...

Embodiment 3

[0080] Prescription: 5 grams of Desmodium, 2.5 grams of Gardenia, 1.5 grams of Cortex Phellodendri, 2 grams of Semen Cassiae, 1.5 grams of Chuanxiong, 2 grams of Magnolia officinalis, 1.5 grams of Moutan Cortex, 1 gram of Sun-dried Ginseng, and 1.5 grams of Guizhi.

[0081] 1. Extract the Semen Cassiae, Magnolia Magnolia officinalis, and Sun-dried Ginseng containing 80% ethanol as a solvent, and after concentration, obtain an extract of the alcohol extract, with a relative density of about 1.10 (50° C.);

[0082] 2. Steam distill the Cortex Moutan of the described weight ratio, collect 7 times the amount (by medicinal material weight) distillate, refrigerate overnight, filter to obtain paeonol crystals; paeonol crystals add appropriate amount of ethanol after dissolving , use β-CD for inclusion, dry the inclusion, and pulverize into fine powder to obtain inclusion A, which is set aside.

[0083] 3. Extract the volatile oil from the cassia twigs, chuanxiong and Desmodium in the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A Chinese medicine for treating cholecystopathy is prepared from 5-9 Chinese-medicinal materials including lysimachia, Chuan-xiong rhizome, cassia seed, cinammon twigs, etc.

Description

technical field [0001] The invention belongs to a pharmaceutical composition for treating gallbladder disease derived from traditional Chinese medicine and a preparation method thereof, in particular to a pharmaceutical composition for treating cholelithiasis and / or cholecystitis and an industrially applicable preparation method thereof. Background technique [0002] Cholelithiasis is characterized by right upper quadrant pain, right shoulder pain, bitter mouth and constipation, or yellow body and eyes as the main clinical manifestations. Chinese medicine believes that the gallbladder is attached to the liver and is the organ of the middle essence. Bile is "formed by borrowing the remaining qi from the liver, overflowing into the gallbladder and accumulating". Emotional disorders, stagnation of liver qi, or stagnation of qi for a long time, stagnation of qi and blood stasis; improper diet, excessive fat and sweetness, dysfunction of the spleen, internal stagnation of dampne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61P1/16
Inventor 陈家进刘俊怡
Owner NANJING TONGRENTANG PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap